Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft
Abstract In lung transplantation (LT), alloreactive T cell priming begins in the graft, a process that can be inhibited by seeding the graft with recipient-derived expanded polyclonal regulatory T cells (Tregs) using ex vivo lung perfusion (EVLP) prior to transplantation. However, this therapy alone...
Saved in:
| Main Authors: | Akihiro Takahagi, Ei Miyamoto, Christina Lam, Mingyao Liu, Betty Joe, Xiaomin Wang, David Hwang, Tereza Martinu, Marcelo Cypel, Shaf Keshavjee, Stephen Juvet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-06835-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ex vivo lung perfusion-to-lung transplant rat survival model with reproducible development of acute lung injury and graft rejection
by: Ei Miyamoto, et al.
Published: (2025-08-01) -
Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferative Disorder
by: Victor H. Ferreira, PhD, et al.
Published: (2025-04-01) -
Adverse Effects of Systemic Immunosuppression in Keratolimbal Allograft
by: M. Krakauer, et al.
Published: (2012-01-01) -
The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01) -
Late Renal Allograft Rupture Associated with Cessation of Immunosuppression following Graft Failure
by: Sumayah Askandarani, et al.
Published: (2011-01-01)